Literature DB >> 15935515

Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.

Seok Jin Kim1, Zahid N Rabbani, Mark W Dewhirst, Zeljko Vujaskovic, Robin T Vollmer, Ernst-Gilbert Schreiber, Egbert Oosterwijk, Michael J Kelley.   

Abstract

Endogenous hypoxia markers have been studied as prognostic indicators because they appear to be associated with tumor aggressiveness. This study was undertaken to compare the expression of two endogenous hypoxia markers, Hypoxia-inducible factor-1alpha (HIF-1alpha) and carbonic anhydrase IX (CA IX), with regard to their prognostic significance. We also compared spatial distribution of HIF-1alpha and CA IX and examined their relationship with expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9, which may be regulated by hypoxia. We studied 74 resected stage I/II non-small cell lung cancers (NSCLCs) for expression of HIF-1alpha, CA IX, VEGF, and MMP-9 by immunohistochemistry, and the extent of tumor necrosis. Univariate and multivariate analyses were performed to assess prognostic implications of these markers for disease free survival. HIF-1alpha expression was strongly correlated with CA IX (r=0.667, p<0.001) and was co-localized with CA IX in corresponding areas. HIF-1alpha and CA IX expression were higher in areas with moderate to severe tumor necrosis relative to areas with minimal necrosis, suggesting their relationship with hypoxia. VEGF expression also showed a modest relationship with HIF-1alpha (p=0.07); however, there was no relationship between HIF-1alpha and MMP-9 expression (p>0.99). Expression of HIF-1alpha and CA IX above the median value was significantly associated with shorter disease free survival in univariate analysis (p<0.05). However, only high CA IX expression and pathologic stage were independent prognostic indicators in a multivariate analysis. Of the markers considered in this study, CA IX expression status was the most reliable hypoxia marker for predicting tumor aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935515     DOI: 10.1016/j.lungcan.2005.03.036

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  66 in total

1.  Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.

Authors:  Mitchell L Ramsey; Benjamin J Yuh; Matthew T Johnson; Anjana V Yeldandi; Debra L Zynger
Journal:  Virchows Arch       Date:  2011-12-06       Impact factor: 4.064

2.  MiR-199a suppresses the hypoxia-induced proliferation of non-small cell lung cancer cells through targeting HIF1α.

Authors:  Gang Ding; Gang Huang; He-dai Liu; Hong-xiang Liang; Yu-feng Ni; Zhao-heng Ding; Guo-ying Ni; Hong-wei Hua
Journal:  Mol Cell Biochem       Date:  2013-12       Impact factor: 3.396

3.  Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.

Authors:  Zhongmian Zhang; Ping Liu; Jian Wang; Tianxiao Gong; Fang Zhang; Jun Ma; Na Han
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

4.  Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia.

Authors:  Vasiliy V Polosukhin; William E Lawson; Aaron P Milstone; Svetlana M Egunova; Andrey G Kulipanov; Sergey G Tchuvakin; Pierre P Massion; Timothy S Blackwell
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

5.  Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer.

Authors:  Jian Chen; Lijuan Hu; Fan Zhang; Junjun Wang; Jie Chen; Yumin Wang
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

6.  A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.

Authors:  C Ostheimer; M Bache; A Güttler; M Kotzsch; D Vordermark
Journal:  Strahlenther Onkol       Date:  2013-12-11       Impact factor: 3.621

7.  The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model.

Authors:  Baocun Sun; Shiwu Zhang; Danfang Zhang; Yanjun Gu; Wenchao Zhang; Xiulan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-16       Impact factor: 4.553

Review 8.  Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Authors:  Eline E Verwer; Ronald Boellaard; Astrid Am van der Veldt
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma.

Authors:  Man Li; Yanjun Gu; Zhiguang Zhang; Shiwu Zhang; Danfang Zhang; Ali F Saleem; Xiulan Zhao; Baocun Sun
Journal:  Pathol Oncol Res       Date:  2009-12-17       Impact factor: 3.201

10.  Regulation of hypoxia-inducible genes by ETS1 transcription factor.

Authors:  Konstantin Salnikow; Olga Aprelikova; Sergey Ivanov; Sean Tackett; Monika Kaczmarek; Aldona Karaczyn; Herman Yee; Kazimierz S Kasprzak; John Niederhuber
Journal:  Carcinogenesis       Date:  2008-04-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.